Found 5 matching trials
Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
PHASE3The purpose of this study in AML patients is to test whether vadastuximab t...
Location
University of Arkansas for Medical Sciences
Radiostereometric Analysis of Fracture Healing in Distal Femur Fractures
N/AThe investigators are doing this research study to look at how distal femor...
Location
Massachusetts General Hospital
A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML
PHASE1This study will examine the safety profile of vadastuximab talirine (SGN-CD...
Location
University of Alabama at Birmingham
A Safety Study of SGN-CD33A in AML Patients
PHASE1This study will examine the safety profile of vadastuximab talirine (SGN-CD...
Location
University of Alabama at Birmingham
Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS
PHASE1This is a phase 1/2 study to evaluate the combination of vadastuximab talir...
Location
Banner MD Anderson Cancer Center